Correlation Between Eli Lilly and I Mab
Can any of the company-specific risk be diversified away by investing in both Eli Lilly and I Mab at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eli Lilly and I Mab into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eli Lilly and and I Mab, you can compare the effects of market volatilities on Eli Lilly and I Mab and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eli Lilly with a short position of I Mab. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eli Lilly and I Mab.
Diversification Opportunities for Eli Lilly and I Mab
Poor diversification
The 3 months correlation between Eli and IMAB is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Eli Lilly and and I Mab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on I Mab and Eli Lilly is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eli Lilly and are associated (or correlated) with I Mab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of I Mab has no effect on the direction of Eli Lilly i.e., Eli Lilly and I Mab go up and down completely randomly.
Pair Corralation between Eli Lilly and I Mab
Considering the 90-day investment horizon Eli Lilly and is expected to under-perform the I Mab. But the stock apears to be less risky and, when comparing its historical volatility, Eli Lilly and is 2.85 times less risky than I Mab. The stock trades about -0.13 of its potential returns per unit of risk. The I Mab is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest 106.00 in I Mab on September 14, 2024 and sell it today you would earn a total of 0.00 from holding I Mab or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Eli Lilly and vs. I Mab
Performance |
Timeline |
Eli Lilly |
I Mab |
Eli Lilly and I Mab Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Eli Lilly and I Mab
The main advantage of trading using opposite Eli Lilly and I Mab positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eli Lilly position performs unexpectedly, I Mab can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in I Mab will offset losses from the drop in I Mab's long position.Eli Lilly vs. Johnson Johnson | Eli Lilly vs. Bristol Myers Squibb | Eli Lilly vs. AbbVie Inc | Eli Lilly vs. Pfizer Inc |
I Mab vs. Puma Biotechnology | I Mab vs. Iovance Biotherapeutics | I Mab vs. Day One Biopharmaceuticals | I Mab vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Stocks Directory Find actively traded stocks across global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |